Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John M Corman

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Urology|March 22, 2022
Opioid-Limiting Pain Control After Transurethral Resection of the Prostate: A Randomized Controlled TrialRyan P Donahue, Andrew W Stamm, Adam M Daily, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2016
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized TrialEmmanuel S Antonarakis, Adam S Kibel, Evan Y Yu, et al.
The Journal of Molecular Diagnostics : JMD|December 26, 2012
Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomyDimo Dietrich, Oliver Hasinger, Lionel L Bañez, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Urology|March 22, 2022
Opioid-Limiting Pain Control After Transurethral Resection of the Prostate: A Randomized Controlled TrialRyan P Donahue, Andrew W Stamm, Adam M Daily, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2016
Sequencing of Sipuleucel-T and Androgen Deprivation Therapy in Men with Hormone-Sensitive Biochemically Recurrent Prostate Cancer: A Phase II Randomized TrialEmmanuel S Antonarakis, Adam S Kibel, Evan Y Yu, et al.
The Journal of Molecular Diagnostics : JMD|December 26, 2012
Development and clinical validation of a real-time PCR assay for PITX2 DNA methylation to predict prostate-specific antigen recurrence in prostate cancer patients following radical prostatectomyDimo Dietrich, Oliver Hasinger, Lionel L Bañez, et al.
Pageof 4